FDA Panel Does Not Recommend Cipro Dispersion for Inhalation FDA Panel Does Not Recommend Cipro Dispersion for Inhalation
An FDA panel did not recommend ciprofloxacin dispersion for inhalation for non-cystic fibrosis bronchiectasis in patients with chronic lung infections with Pseudomonas aeruginosa.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news